Diagnostic accuracy for colorectal cancer of a quantitative faecal immunochemical test in symptomatic primary care patients: a study protocol

Anna Lööv, Cecilia Högberg, Mikael Lilja, Elvar Theodorsson, Per Hellström, Alexandra Metsini, Louise Olsson, Anna Lööv, Cecilia Högberg, Mikael Lilja, Elvar Theodorsson, Per Hellström, Alexandra Metsini, Louise Olsson

Abstract

Background: There is increasing evidence supporting the use of faecal immunochemical tests (FIT) in patients reporting symptoms associated with colorectal cancer (CRC), but most studies until now have focused on selected subjects already referred for investigation. We therefore set out to determine the accuracy and predictive values of FIT in a primary care population.

Method: A prospective, multicentre, single-gated comparative diagnostic study on quantitative FIT in patients aged 40 years and above presenting in primary care with symptoms associated with CRC will be conducted. Patients representing the whole spectrum of severity of such symptoms met with in primary care will be eligible and identified by GPs. Participants will answer a short form on symptoms during the last month. They will provide two faecal samples from two separate days. Analyses will be performed within 5 days (QuikRead go®, Aidian Oy). The analytical working range is 10-200 μg Hb/g faeces. Reference test will be linked to the Swedish Colorectal Cancer Registry up to 2 years after inclusion. Accuracy, area under ROC curves, and predictive values will be calculated for one FIT compared to the highest value of two FIT and at cutoff < 10, 10-14.9, 15-19.9 and ≥ 20 μg Hb/g faeces. Subgroup analyses will be conducted for patients with anaemia and those reporting rectal bleeding. A model-based cost-effectiveness analysis based on the clinical accuracy study will be performed. Based on previous literature, we hypothesized that the sensitivity of the highest value of two FIT at cutoff 10 μg Hb/g faeces will be 95% (95% CI + / - 15%). The prevalence of CRC in the study population was estimated to be 2%, and the rate of non-responders to be 1/6. In all, 3000 patients will be invited at 30 primary care centres.

Discussion: This study will generate important clinical real-life structured data on accuracy and predictive values of FIT in the most critical population for work-up of CRC, i.e. patients presenting with at times ambiguous symptoms in primary care. It will help establish the role of FIT in this large group.

Trial registration: NCT05156307 . Registered on 14 December 2021-retrospectively registered.

Keywords: Colorectal cancer; Diagnostic accuracy study; Primary care; Quantitative faecal immunochemical test; Sensitivity.

Conflict of interest statement

The authors declare no conflict of interest. Aidian Oy lend three QuikRead go® instruments for study purposes.

© 2022. The Author(s).

References

    1. World Health Organization. . Accessed 8 Dec 2021.
    1. Wools A, Dapper EA, de Leeuw JR. Colorectal cancer screening participation: a systematic review. Eur J Public Health. 2016;26:158–168. doi: 10.1093/eurpub/ckv148.
    1. Adelstein BA, Macaskill P, Chan SF, Katelaris PH, Irwig L. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterol. 2011;11:65. doi: 10.1186/1471-230X-11-65.
    1. Westwood M, Lang S, Armstrong N, van Turenhout S, Cubiella J, Stirk L, et al. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Med. 2017;15:189. doi: 10.1186/s12916-017-0944-z.
    1. Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L, et al. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost- effectiveness analysis. Health Technol Assess. 2017;21:1–234. doi: 10.3310/hta21330.
    1. Tsapournas G, Hellström PM, Cao Y, Olsson LI. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy. Scand J Gastroenterol. 2020;55(2):184–92. doi: 10.1080/00365521.2019.1708965.
    1. Herrero JM, Vega P, Salve M, Bujanda L, Cubiella J. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study. BMC Gastroenterol. 2018;18(1):155. doi: 10.1186/s12876-018-0887-7.
    1. Leeflang MM, Rutjes AW, Reitsma JB, Hooft L, Bossuyt PM. Variation of a test's sensitivity and specificity with disease prevalence. CMAJ. 2013;185(11):E537–E544. doi: 10.1503/cmaj.121286.
    1. Juul JS, Hornung N, Andersen B, Laurberg S, Olesen F, Vedsted P. The value of using the faecal immunochemical test in general practice on patients presenting with non- alarm symptoms of colorectal cancer. Br J Cancer. 2018;119(4):471–479. doi: 10.1038/s41416-018-0178-7.
    1. Nicholson BD, James T, Paddon M, et al. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests. Aliment Pharmacol Ther. 2020;52:1031–1041.
    1. Bailey SER, Abel GA, Atkins A, Byford R, Davies SJ, Mays J, et al. Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England. Br J Cancer. 2021;124(7):1231–1236. doi: 10.1038/s41416-020-01221-9.
    1. Chapman C, Thomas C, Morling J, Tangri A, Oliver S, Simpson JA, et al. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham. Colorectal Dis. 2020;22(6):679–688. doi: 10.1111/codi.14944.
    1. Baughan P, Keatings J, O'Neill B. Urgent suspected cancer referrals from general practice: audit of compliance with guidelines and referral outcomes. Br J Gen Pract. 2011;61(592):e700–e706. doi: 10.3399/bjgp11X606591.
    1. Högberg C, Gunnarsson U, Cronberg O, Thulesius H, Lilja M, Jansson S. Qualitative faecal immunochemical tests (FITs) for diagnosing colorectal cancer in patients with histories of rectal bleeding in primary care: a cohort study. Int J Colorectal Dis. 2020;35(11):2035–2040. doi: 10.1007/s00384-020-03672-1.
    1. Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer. 2011;104(11):1779–1785. doi: 10.1038/bjc.2011.160.
    1. Li M, Cao Y, Olsson L. A population-based study on time trends of hemoglobin in primary care comparing prediagnostic colorectal cancer patients vs age- and sex-matched controls. Scand J Gastroenterol. 2021;56(3):266–273. doi: 10.1080/00365521.2021.1879245.
    1. Väyrynen JP, Tuomisto A, Väyrynen SA, Klintrup K, Karhu T, Mäkelä J, et al. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival. Sci Rep. 2018;8(1):1126. doi: 10.1038/s41598-018-19572-y.
    1. Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC, Bossuyt PM. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11). 10.1136/bmjopen-2016-012799.
    1. Wilkens J, Thulesius H, Schmidt I, Carlsson C. The 2015 National Cancer Program in Sweden: Introducing standardized care pathways in a decentralized system. Health Policy. 2016;120(12):1378–1382. doi: 10.1016/j.healthpol.2016.09.008.
    1. Nieuwenburg SAV, Vuik FER, Kruip MJHA, Kuipers EJ, Spaander MCW. Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis. Gut. 2019;68(5):866–872. doi: 10.1136/gutjnl-2018-316344.
    1. O'Driscoll S, Carroll M, Maclean W, Piggott C, Jourdan I, Benton SC. Assessment of the analytical performance of point-of-care faecal immunochemical tests for haemoglobin. Ann Clin Biochem. 2021;58(3):181–189. doi: 10.1177/0004563220986595.
    1. Moberger P, Sköldberg F, Birgisson H. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity. Acta Oncol. 2018;57(12):1611–1621. doi: 10.1080/0284186X.2018.1529425.
    1. Auge JM, Fraser CG, Rodriguez C, Roset A, Lopez-Ceron M, Grau J, et al. Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients. Clin Chem Lab Med. 2016;54(1):125–132. doi: 10.1515/cclm-2015-0388.
    1. Korevaar DA, Gopalakrishna G, Cohen JF, Bossuyt PM. Targeted test evaluation: a framework for designing diagnostic accuracy studies with clear study hypotheses. Diagn Progn Res. 2019;3:22. doi: 10.1186/s41512-019-0069-2.
    1. Högberg C, Gunnarsson U, Jansson S, Thulesius H, Cronberg O, Lilja M. Diagnosing colorectal cancer in primary care: cohort study in Sweden of qualitative faecal immunochemical tests, haemoglobin levels, and platelet counts. Br J Gen Pract. 2020;70(701):e843–e851. doi: 10.3399/bjgp20X713465.
    1. World Health Organization. Accessed 8 Dec 2021.
    1. Drummond MF, Sculpher, M.J., Torrance, G.W., O'Brien, B.J., Stoddartm, G.L. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed: Oxford University Press; 2005.
    1. Cost-per-patient Database. Sveriges Kommuner och Regioner, Stockholm. . Accessed 17 Januari 2022.
    1. Edlin R, et al. Cost Effectiveness Modelling for Health Technology Assessment. A Practical Course: Springer International Publishing Switzerland; 2015.
    1. Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, Orlewska E, Penna P, Rodriguez Barrios JM, Shau WY, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5–14. doi: 10.1016/j.jval.2013.08.2291.
    1. National Institute for Health and Care Excellence. Accessed 8 Dec 2021.
    1. Cunin L, Khan AA, Ibrahim M, Lango A, Klimovskij M, Harshen R. FIT negative cancers: A right-sided problem? Implications for screening and whether iron deficiency anaemia has a role to play. Surgeon. 2021;19(1):27–32. doi: 10.1016/j.surge.2020.02.003.
    1. Statistics database for operations. National Board of Health and Welfare, Stockholm. Accessed 20 Dec 2021.
    1. Siegel RL, Torre LA, Soerjomataram I, Hayes RB, Bray F, Weber TK, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179–2185. doi: 10.1136/gutjnl-2019-319511.
    1. von Wagner C, Verstraete W, Hirst Y, Nicholson BD, Stoffel ST, Laszlo H. Public preferences for using quantitative faecal immunochemical test versus colonoscopy as diagnostic test for colorectal cancer: evidence from an online survey. BJGP Open. 2020;4(1). doi: 10.3399/bjgpopen20X101007.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner